Regulatory and Market Access Outsourcing
Navigating the complex French "HAS" (Haute Autorité de Santé) reimbursement landscape is a major hurdle for international firms. Consequently, a robust market for Regulatory Affairs and Market Access Outsourcing has emerged in 2026.
These specialized consultancies provide localized expertise in "Health Technology Assessment" (HTA). They manage the entire value-dossier process, ensuring that outsourced products are positioned correctly for pricing negotiations with the French government. This strategic outsourcing is essential for any biotech company aiming for a successful commercial launch in one of Europe’s largest drug markets.
2 Views